Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

PBYI

PUMA BIOTECHNOLOGY, INC.

CIK 0001401667 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$9.24
↑ 0.13 (1.43%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership, Technicals, Options

Key stats

Market Cap
$476.97M
P/E Ratio
17.85
EPS
0.62
Dividend Yield
Not covered
52W Position
95%
Beta
0.56

Valuation multiples

Fwd P/E
3.46
PEG
0.03
P/B
3.44
P/S
2.06
EV/Revenue
1.90
ROE
19.3%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 95%
$4.30$9.51

Latest Financials

2025-12-31 FY
Revenue
$228.37M
Net Income
$31.11M
Total Assets
$216.30M
Free Cash Flow
$41.73M

Recent news